Sutro Biopharma STRO Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$153.6M+37.4% | -$191.09M+16.0% | -$216.77M— | -$208.7M— | -$245.22M— | ||
| $6.7M-8.9% | $7.32M+1.5% | $7.57M+6.9% | $7.47M+6.4% | $7.36M+5.7% | ||
| $10.03M-58.5% | $14.01M-43.3% | $18.27M-26.9% | $23.26M-4.9% | $24.16M-3.2% | ||
| -$151.61M+25.7% | -$177.23M+11.8% | -$222.53M— | -$248.86M— | -$204.14M— | ||
| —— | —— | —— | —— | —— | ||
| $16.01M-88.4% | $45.01M-79.4% | $113.8M+5.9% | $221.1M+244% | $138.15M+2,000% | ||
| —— | —— | —— | —— | —— | ||
| —— | $0— | —— | —— | —— | ||
| —— | —— | —— | —— | $97.57M— | ||
| -$34.45M-184% | -$134.08M-211% | -$110.55M— | -$26.76M— | $41.01M— | ||
| -$151.59M+25.9% | -$177.24M+12.2% | -$222.6M— | -$249.43M— | -$204.71M— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Sutro Biopharma generate?
- Sutro Biopharma (STRO) generated -$151.6M in operating cash flow over the trailing twelve months.
- What is Sutro Biopharma's free cash flow?
- After $627.0K of capital expenditures, Sutro Biopharma's free cash flow was -$151.6M over the trailing twelve months, up 25.9% year over year.
- Where does Sutro Biopharma's cash flow data come from?
- Every line is extracted from Sutro Biopharma's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
